Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04317404 · ClinicalTrials.gov registry record
Knee Steroid Injection and Blood Sugar Signatur
A clinical trial, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- 11
- Enrollment target
NCT04317404 is a clinical trial that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 11 participants.
The verdict
NCT04317404 has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
Study Summary
A prospective, observational study assessing the relationship between HbA1c level and the post-injection blood glucose signature. Participants will be non-diabetic, pre-diabetic, non-insulin dependent and insulin dependent type 2 diabetic patients who will be receiving a knee steroid injection. All of them will be consented a week prior to the injection, when the CGM sensor will be applied to the back of the upper arm. This will be removed a week after the injection. KOOS survey as well as VAS will be administered. Adverse events (e.g., change in medication or hospitalization) will be monitored throughout the study.
Interventions
- DRUG 40 mg Triamcinolone acetonide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2022-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04317404
The ClinicalTrials.gov registry entry for NCT04317404 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 40 mg Triamcinolone acetonide is the first listed.
NCT04317404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04317404 about?
NCT04317404 is a clinical study titled "Knee Steroid Injection and Blood Sugar Signatur". A prospective, observational study assessing the relationship between HbA1c level and the post-injection blood glucose signature. Participants will be non-diabetic, pre-diabetic, non-insulin dependent and insulin dependent type 2 diabetic patients who will be receiving a knee steroid injection. All ...
What is the current status of trial NCT04317404?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2020-11-01. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04317404?
The interventions under investigation include: 40 mg Triamcinolone acetonide (DRUG).
Who is sponsoring clinical trial NCT04317404?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.